Bone Biologics

(NASDAQ) BBLGW

Current Price$14.65

Market CapN/A

Since IPO (2021)-61%

5 YearN/A

1 Year+4%

1 Month-19%

Bone Biologics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.86M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$14.65

Volume

916

Open

$14.20

Price

$14.65

Volume

916

Open

$14.20

Previous Close

$14.00

Daily Range

$14.00 - $15.00

52-Week Range

$8.30 - $35.95

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$14.65

Volume

916

Open

$14.20

Previous Close

$14.00

Daily Range

$14.00 - $15.00

52-Week Range

$8.30 - $35.95

Estimated Earnings Date

Sep 2, 2026

BBLGW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bone Biologics

Industry

Biotechnology

Sector

Health Care

Headquarters

Burlington, MA 01803, US

BBLGW Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-64%

Return on Assets

-57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

916

Avg. Volume

353.031

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$3.23M

EBITDA

-$3.11M

Operating Cash Flow

-$2.69M

Capital Expenditure

$0.00

Free Cash Flow

-$2.69M

Cash & ST Invst.

$5.33M

Total Debt

$0.00

Bone Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$765.99K

+24.7%

EBITDA

-$805.05K

+22.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.53M

+64.9%

Accounts Receivable

$7.81K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-57.40%

N/A

Return on Invested Capital

-64.27%

N/A

Free Cash Flow

-$804.28K

+13.2%

Operating Cash Flow

-$804.28K

+13.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NAOVNanoVibronix, Inc.

NAOVNanoVibronix, Inc.$1.90+1.06%

MOVECorvex, Inc.

MOVECorvex, Inc.$18.68-9.80%

VEROVenus Concept Inc.

VEROVenus Concept Inc.$0.31+2.64%

DHAIDIH Holding US, Inc.

DHAIDIH Holding US, Inc.$0.00+0.00%

BGMSBio Green Med Solution, Inc.

BGMSBio Green Med Solution, Inc.$1.50+41.51%

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$1.94-2.27%

RDHLRedHill Biopharma Ltd.

RDHLRedHill Biopharma Ltd.$1.03+3.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About BBLGW

What is the current price of Bone Biologics?

Bone Biologics is trading at $14.00 per share.

What is the 52-week range for Bone Biologics?

Over the past 52 weeks, Bone Biologics has traded between $8.30 and $35.95.

How much debt does Bone Biologics have?

Bone Biologics total debt is unavailable.

How much cash does Bone Biologics have on hand?

Bone Biologics does not have cash on hand data available.

What is Bone Biologics’s dividend yield?

Bone Biologics does not currently have a dividend yield.

Bone Biologics

Bone Biologics Financials at a Glance

BBLGW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bone Biologics

BBLGW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bone Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BBLGW

What is the current price of Bone Biologics?

What is the 52-week range for Bone Biologics?

How much debt does Bone Biologics have?

How much cash does Bone Biologics have on hand?

What is Bone Biologics’s dividend yield?

Premium Investing Services